Kenneth Lynard

Kenneth Lynard is a seasoned finance executive with extensive experience in the pharmaceutical and medical services sectors. Currently serving as Chief Financial Officer at Pharming Group since 2025, Kenneth previously held significant roles such as Managing Director and Group CFO at Schoeller Allibert and Board Member & Group CFO at Zentiva, where expertise in private equity, value creation, and growth was demonstrated. Kenneth's career also includes pivotal positions at Affidea and Gilead Sciences, where leadership in cash generation, turnaround strategies, and operational management was emphasized. Kenneth holds an Executive MBA from IMD and a Master of Science in Business Economics & Auditing from Copenhagen Business School.